Status:
ACTIVE_NOT_RECRUITING
Opiophobia in Postsurgical Adults With Cancer
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
Sigma Theta Tau International
Conditions:
Opiophobia
Eligibility:
All Genders
18+ years
Brief Summary
To learn how people who underwent surgery feel about their prescribed opioid medication after they leave the hospital.
Detailed Description
To explore the barriers and fears related to use of opioids among a population of adults who underwent surgery for cancer who were prescribed opioids for home use during the first week following hospi...
Eligibility Criteria
Inclusion
- Adult patient with cancer admitted for cancer-related surgery
- inpatient surgical hospital stay lasting at least 23 hours
- discharged home with a prescription for opioid analgesics
- able to read, speak, and consent in English.
Exclusion
- Age less than 18 years
- not discharged with a prescription for opioid analgesia to manage pain
- individuals for whom there is documentation of inability to provide consent in the medical record.
Key Trial Info
Start Date :
September 16 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06536283
Start Date
September 16 2024
End Date
December 31 2026
Last Update
October 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Univerisity of Texas M. D. Anderson Cancer Center
Houston, Texas, United States, 77030